MoneyWorks4Me

Astal Laboratories - Quaterly Results

27 Jan 2025 Evaluate
The turnover is pegged at Rs. 144.59 millions for the December 2024 quarter. The mentioned figure indicates a rise of about 71.89% as against Rs. 84.12 millions during the year-ago period.The Total revenue for the quarter ended December 2024 of  Rs. 24.88  millions  grew by 410.88% from Rs. 4.87 millions.The company reported a good operating profit of 33.79 millions compared to 4.95 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 144.59 84.12 71.89 407.65 220.23 85.10 236.48 34.28 589.85
Other Income 0.56 0.00 0.00 0.90 0.12 650.00 0.13 1.79 -92.74
PBIDT 33.79 4.95 582.63 86.83 10.88 698.07 11.17 0.40 2692.50
Interest 2.81 0.00 0.00 4.35 0.00 0.00 0.00 0.00 0.00
PBDT 30.98 4.95 525.86 82.48 10.88 658.09 11.17 0.40 2692.50
Depreciation 0.81 0.08 912.50 1.19 0.30 296.67 0.30 0.08 275.00
PBT 30.17 4.87 519.51 81.29 10.58 668.34 10.87 0.32 3296.88
TAX 5.29 0.00 0.00 19.48 0.00 0.00 3.02 0.16 1787.50
Deferred Tax 0.97 0.00 0.00 1.22 0.00 0.00 0.08 0.06 33.33
PAT 24.88 4.87 410.88 61.81 10.58 484.22 7.85 0.16 4806.25
Equity 98.46 49.40 99.31 98.46 98.46 0.00 98.46 39.90 146.77
PBIDTM(%) 23.37 5.88 297.14 21.30 4.94 331.15 4.72 1.17 304.78
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..